Welcome to the EBF 3rd Annual Open Symposium and the Dried Blood Spot meeting
We are pleased to announce the start of the plans for the EBF open symposium in 2010. After the success of the 2nd Open Symposium in 2009 with over 400 delegates we have selected dates and topics for the 3rd Annual Open Symposium, again in Barcelona :
Dried Blood Spot Meeting
17th to 18th of June 2010
Sheraton, Brussels, Belgium
The EBF is organising a meeting on Dried Blood Spots, in Brussels in June. For full details of this meeting http://sites.google.com/site/ebfdbs/,
___________________________________________________________________________________________
From Challenges to Solutions, The 3rd EBF Open Symposium
1nd to 3th of December 2010
Hesperia Towers, Barcelona, Spain
To download the call for sponsors:
http://www.bioanalysis-forum.com/medias/download/call for sponsors open- 2010.pdf
The European Bioanalysis Forum
The European Bioanalysis Forum (EBF) is an organisation comprised of (Global and EU-based) pharmaceutical companies with operational activities in the EU, 27 member companies to date. The membership shares a common vision to advance our understanding of topical concerns through discussion of scientific, technological and regulatory issues of bioanalytical interest. To learn more about the EBF: Website: http://www.europeanbioanalysisforum.eu/
MEETING ORGANISATION
SCIENTIFIC CONTENT OF MEETING AND EBF STEERING COMMITTEE Philip Timmerman, Johnson&Johnson, Berthold Lausecker, F Hoffmann-La Roche Ltd, Margarete Brudny-Kloeppel, Bayer Schering Pharma AG, Silke Luedtke, Boehringer Ingelheim, Peter van Amsterdam, Solvay Pharmaceuticals
SPONSOR RELATIONS, MARKETING AND LOGISTICS Christina Smith, Celerion and Bavalan Bioconference
The conference is organized by European Bioanalysis Forum VZW, who has assigned Christina Smith (SARL Bavalan Bioconference/Celerion) as the conference manager, responsible for all logistical aspects of organizing the conference.
EBF member companies:
- Abbott ,
- Actelion Ltd,
- Active Biotech
- Almirall
- Astellas
- AstraZeneca
- Bayer Schering Pharma AG
- Boehringer-Ingelheim
- Eisai
- Ferring Pharmaceuticals A/S
- Grünenthal GmbH
- GSK
- F. Hoffmann-La Roche
- Johnson & Johnson
- H. Lundbeck A/S
- Merck&Co
- Merck Serono
- Novartis Pharma AG
- Novo Nordisk
- Nycomed
- Schering-Plough
- Orion Corp. Orion Pharma
- Pfizer
- Sanofi-Aventis
- Servier
- Shire Pharmaceuticals
- UCB Pharma